Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| N° IDRCB: 2025-A02326-43 | Other Identifier | RDS SAS |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Assessing the clinical and organisational impact of a home-based post-operative monitoring strategy incorporating the MultiSense® device involving 80 patients aged 65 years and over who have undergone major surgery.
Evaluate the clinical and organisational impact of a post-operative home monitoring strategy incorporating the MultiSense® device in elderly patients.
The study will be conducted in a multicentre setting, involving 80 patients aged 65 years and over who have undergone major surgery.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MS | Experimental | All patients will be monitored at home with the medical device MultiSense® |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Monitoring by MultiSense | Device | The MultiSense device will be placed on the patient's back and will allow physicians to remotely monitor six biological parameters |
|
| Measure | Description | Time Frame |
|---|---|---|
| The percentage of patients whose care was deemed satisfactory | The quality of surgical care will be assessed using a "textbook outcome" (TO) composed of the 2 following criteria :
| 7 days |
| Measure | Description | Time Frame |
|---|---|---|
| Average length of initial hospital stay following surgery | 7 days | |
| Percentage of patients requiring unscheduled care related to surgery at 30 days | Patients requiring unplanned readmission and/or a visit to the emergency department |
| Measure | Description | Time Frame |
|---|---|---|
| Temporal distribution of complications by severity level according to the Clavien-Dindo classification between the day of surgery and day 30 | To assess the impact of the treatment pathway on the timing and severity of complications | A 30-days period |
| Mapping of complications according to the following classification : complications of severity 1 to 2 and complications of severity 3 or higher according to the Clavien-Dindo classification at the end of remote monitoring and at day 30 |
Inclusion Criteria :
Patient aged 65 or over
Patient eligible for remote monitoring using the MultiSense® device
No psychiatric illness that would prevent them from giving informed consent or receiving optimal treatment and follow-up care
Subject affiliated with a health insurance scheme
Subject able to read and understand English
Subject who has signed an informed consent form
Subjects indicated for scheduled surgery
Patients indicated for scheduled surgery :
Exclusion Criteria :
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Western Cancer Institute of Angers | Not yet recruiting | Angers | 49000 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 30 days |
| Percentage of patients with at least one unplanned rehospitalization following telemonitoring and at 30 days | 30 days |
| Percentage of patients with at least one visit to the emergency department following telemonitoring and at day 30 | 30 days |
| Percentage of patients with at least one grade 3 to 5 complication according to the Clavien-Dindo classification at 30 days | The Clavien-Dindo classification is a system used in surgery to classify postoperative complications according to their severity | 30 days |
| Number of unplanned rehospitalizations and/or emergency department visits at 30 days (total and per patient) | 30 days |
| Number of unscheduled visits (to a general practitioner or a surgeon) at 30 days (total and per patient) | 30 days |
| Quality of postoperative recovery using the French version of the fQoR-15 scale at hospital discharge (V2) and at 30 days (V4) | Assess the impact on patient's quality of life fQoR-15 : French Quality of Recovery-15 15 : corresponds to the 15 multidimensional questions that make up the score. The total score ranges from 0 to 150 The higher the score, the better the quality of post-operative recovery High score = optimal recovery Low score = impaired recovery | 30 days |
| Measurement of the overall index score for the EQ-5D-5L questionnaire at preoperative assessment (V0), at hospital discharge (V2), and at 30 days (V4) | Assess the impact on patients' quality of life EQ : EuroQol, the name of the international research group that developed this tool. 5D : 5 dimensions of health assessed (mobility, independence, daily activities, pain/discomfort, and anxiety/depression). 5L : 5 levels, the 5 possible severity levels for each dimension :
| 30 days |
| Total length of hospital stay (initial admission and readmission) at 30 days | Assess the organizational impact associated with the deployment of the MULTISENSE® solution based on the HAS's mapping | 30 days |
| DAOH30 (Days Alive and Out of Hospital) or Days of Independence at Home at Day 30, defined as the number of days during which the patient recovered independently at home without requiring hospitalization or rehospitalization, during the 30-day postoper | This outcome will be calculated using the following formula : DAOH30 = 30 days - (initial length of stay + duration of readmissions) | 30 days |
| Percentage of patients who did not comply with remote monitoring via MultiSense® (non-compliance is defined as the patient discontinuing monitoring before reaching 80% of the scheduled duration, which corresponds to the 4th day) | Assess patient and healthcare professional satisfaction with and usability of the solution | 4th day |
| Average usability score reported by healthcare professionals using the French version of the SUS (System Usability Scale) questionnaire completed at the end of the study | SUS : System Usability Scale Minimum value : 0 Maximum value : 100 Interpretation of the score : A high score indicates a positive result. The closer the score is to 100, the more the system (in this case, the MultiSense® solution) is considered to be user-friendly, intuitive and satisfactory for healthcare professionals. Conversely, a low score indicates poor usability. | 8 months |
| Level of patient satisfaction as measured by a specific questionnaire completed following the remote monitoring session | This is an 'ad hoc' satisfaction questionnaire (specifically designed for the purposes of this study). Scale details : The full name given in the appendix is the Patient Satisfaction Questionnaire. It assesses levels of satisfaction with the MultiSense® solution. Scores and interpretation : the exact minimum and maximum scores are not specified, a high score corresponds to a positive result (greater patient satisfaction). | 5th day |
| Level of healthcare professionals' reassurance regarding the patient's return home, assessed by a questionnaire completed at the time of discharge. | This is an 'ad hoc' satisfaction questionnaire (specifically designed for the purposes of this study). Scale details : The full name given in the appendix is the Patient Satisfaction Questionnaire. It assesses levels of satisfaction with the MultiSense® solution. Scores and interpretation : the exact minimum and maximum scores are not specified, a high score corresponds to a positive result (greater patient satisfaction). | Day 1 |
| Level of satisfaction among healthcare professionals, as measured by a specific questionnaire completed at the end of the study | This is an 'ad hoc' satisfaction questionnaire (specifically designed for the purposes of this study). Scale details : The full name given in the appendix is the Patient Satisfaction Questionnaire. It assesses levels of satisfaction with the MultiSense® solution. Scores and interpretation : the exact minimum and maximum scores are not specified, a high score corresponds to a positive result (greater patient satisfaction). | 8 months |
To assess the impact of the treatment pathway on the timing and severity of complications |
| On the 5th day and 30th day |
| Bergonié Insititute | Not yet recruiting | Bordeaux | 33000 | France |
|
| Inter-municipal Hospital Centre of Mont-de-marsan | Not yet recruiting | Mont-de-Marsan | 40000 | France |
|
| Western Cancer Institute of Nantes | Recruiting | Nantes | 44000 | France |
|